Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim Aldoss

Showing results (141-150 of 189) with videos related to

Pageof 19
Sort By:
Blood Advances|June 28, 2024
Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AMLJan Philipp Bewersdorf, Shai Shimony, Rory M Shallis, et al.
American Journal of Hematology|May 28, 2024
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemiaTamer Othman, Paul Koller, Ni-Chun Tsai, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 4, 2019
Allogeneic Hematopoietic Cell Transplantation Outcomes in Patients Carrying Isocitrate Dehydrogenase MutationsAmandeep Salhotra, Michelle Afkhami, Dongyun Yang, et al.
Transplantation and Cellular Therapy|August 9, 2024
Total Body Irradiation and Fludarabine with Post-Transplantation Cyclophosphamide for Mismatched Related or Unrelated Donor Hematopoietic Cell TransplantationShukaib Arslan, Amrita Desai, Dongyun Yang, et al.
Bone Marrow Transplantation|December 18, 2024
Fludarabine melphalan reduced intensity conditioning vs radiation-based myeloablative conditioning in patients undergoing allogeneic transplantation for acute myeloid leukemia with measurable residual diseaseAmanda Blackmon, Michelle Afkhami, Dongyun Yang, et al.
The Lancet. Haematology|May 18, 2026
Total marrow and lymphoid irradiation in combination with cyclophosphamide and etoposide before haematopoietic cell transplantation for relapsed or refractory acute leukaemia: a single-centre, open-label, phase 2 trialAnthony Stein, Yan Wang, Monzr M Al Malki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2017
Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic LeukemiaPartow Kebriaei, Claudio Anasetti, Mei-Jie Zhang, et al.
Transplantation and Cellular Therapy|July 5, 2025
Outcomes after Melphalan-Based Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Renal ImpairmentTina Nguyen, Tanya Markary, Ni-Chun Tsai, et al.
Transplantation and Cellular Therapy|September 27, 2024
A Multicenter Analysis of Allogeneic Transplant Outcomes in Adults with Philadelphia-Like B-Cell Acute Lymphoblastic Leukemia in First Complete RemissionZaid Abdel Rahman, Tamer Othman, Rima M Saliba, et al.
Transplantation and Cellular Therapy|January 22, 2023
Post-Transplantation Sinusoidal Obstruction Syndrome in Adult Patients with B Cell Acute Lymphoblastic Leukemia Treated with Pretransplantation InotuzumabVaibhav Agrawal, Hoda Pourhassan, Ni-Chun Tsai, et al.
Pageof 19

Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
Blood Advances|June 28, 2024
Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AMLJan Philipp Bewersdorf, Shai Shimony, Rory M Shallis, et al.
American Journal of Hematology|May 28, 2024
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemiaTamer Othman, Paul Koller, Ni-Chun Tsai, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 4, 2019
Allogeneic Hematopoietic Cell Transplantation Outcomes in Patients Carrying Isocitrate Dehydrogenase MutationsAmandeep Salhotra, Michelle Afkhami, Dongyun Yang, et al.
Transplantation and Cellular Therapy|August 9, 2024
Total Body Irradiation and Fludarabine with Post-Transplantation Cyclophosphamide for Mismatched Related or Unrelated Donor Hematopoietic Cell TransplantationShukaib Arslan, Amrita Desai, Dongyun Yang, et al.
Bone Marrow Transplantation|December 18, 2024
Fludarabine melphalan reduced intensity conditioning vs radiation-based myeloablative conditioning in patients undergoing allogeneic transplantation for acute myeloid leukemia with measurable residual diseaseAmanda Blackmon, Michelle Afkhami, Dongyun Yang, et al.
The Lancet. Haematology|May 18, 2026
Total marrow and lymphoid irradiation in combination with cyclophosphamide and etoposide before haematopoietic cell transplantation for relapsed or refractory acute leukaemia: a single-centre, open-label, phase 2 trialAnthony Stein, Yan Wang, Monzr M Al Malki, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2017
Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic LeukemiaPartow Kebriaei, Claudio Anasetti, Mei-Jie Zhang, et al.
Transplantation and Cellular Therapy|July 5, 2025
Outcomes after Melphalan-Based Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Renal ImpairmentTina Nguyen, Tanya Markary, Ni-Chun Tsai, et al.
Transplantation and Cellular Therapy|September 27, 2024
A Multicenter Analysis of Allogeneic Transplant Outcomes in Adults with Philadelphia-Like B-Cell Acute Lymphoblastic Leukemia in First Complete RemissionZaid Abdel Rahman, Tamer Othman, Rima M Saliba, et al.
Transplantation and Cellular Therapy|January 22, 2023
Post-Transplantation Sinusoidal Obstruction Syndrome in Adult Patients with B Cell Acute Lymphoblastic Leukemia Treated with Pretransplantation InotuzumabVaibhav Agrawal, Hoda Pourhassan, Ni-Chun Tsai, et al.
Pageof 19